Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Neoplasm Metastasis 2Bulbo-Spinal Atrophy, X-Linked 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer Metastatic Disease 1Prostate Adenocarcinoma 1PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1Metastatic Hormone-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-Resistant Prostate Cancer 1Melanoma 1Esophageal Squamous Cell Carcinoma 1Disease 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bites and Stings 1Advanced Solid Tumor 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 3Observation 2Magnetic Resonance Imaging 2Biopsy 2tislelizumab 1pembrolizumab 1fluorocholine 1atezolizumab 1abiraterone 1Videotape Recording 1TIC10 compound 1Surveys and Questionnaires 1Specimen Handling 1Referral and Consultation 1Prostatectomy 1Preoperative Exercise 1Prednisone 1Positron Emission Tomography Computed Tomography 1Pluvicto 1Nephroureterectomy 1Mass Screening 1Mammography 1Interleukin-15 1High-Intensity Interval Training 1Hematologic Tests 1Food 1Endosonography 1Educational Status 1Diagnostic Techniques and Procedures 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Disease × abiraterone × Clear all
NCT07299292 2025-12-23

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

SMED Clinical Research

Phase 2 Recruiting
60 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡